EUVIMEDEUVIMED entdecken
Crossref

Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes

Peace Asuzu, Naser Aliye, Frankie Stentz, Jim Wan, Nawajes Mandal iD, Samuel Dagogo-Jack iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Peace Asuzu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Sphingolipids, Blood Glucose, Glucose Intolerance, Prediabetic State. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institutes of Diabetes Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Sphingolipids have been linked to the pathogenesis of type 2 diabetes.

Objective

To examine the association of plasma sphingolipids with glycemic measures in adults without diabetes.

Methods

Plasma sphingolipid species (ceramides, monohexosyl ceramides, lactosyl ceramides, sphingomyelins, and sphingosines) were assayed using liquid chromatography tandem mass spectrometry in baseline specimens obtained from participants in the Pathobiology of Prediabetes in a Biracial Cohort study (n = 240) and the Diabetes Prevention Program (n = 280). Based on oral glucose tolerance tests, we identified participants with (1) normal fasting plasma glucose (NFG) (<100 mg/dL) and normal glucose tolerance (NGT) [2-hour plasma glucose (2hPG) < 140 mg/dL]; (2) impaired fasting glucose (IFG; 100-125 mg/dL) with normal 2hPG; (3) impaired glucose tolerance (IGT) (2hPG 140-199 mg/dL with NFG); and (4) IFG and IGT.

Results

The participants (63% female; 48% Black, 52% White) had a mean age of 45.5 ± 9.84 years, body mass index (BMI) 32.4 ± 7.24 kg/m2, fasting plasma glucose (FPG) 99.8 ± 10.5 mg/dL, and 2hPG 145 ± 29.4 mg/dL. FPG and 2hPG levels correlated positively with ceramides, sphingomyelins, and sphingosine and inversely with monohexosyl ceramides, lactosyl ceramides, and sphingosine-1 phosphate levels, adjusted for age, sex, race, and BMI. Plasma ceramides, sphingomyelins, and sphingosine increased progressively across participants with NFG-NGT, isolated IGT, and IFG-IGT, whereas the opposite was seen for monohexosyl ceramides, lactosyl ceramides, and sphingosine-1 phosphate levels (ANOVA P < .0001).

Conclusion

Circulating levels of major sphingolipid species are significantly associated with glycemia and glucose tolerance, indicating a possible link between sphingolipid metabolism and glucoregulation in people without diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingolipidsBlood GlucoseGlucose IntolerancePrediabetic StateHumansFemaleMaleMiddle AgedGlucose Tolerance TestAgedAdultCohort StudiesDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

ceramidefasting plasma glucoseglycated hemoglobinrace/ethnicitysphingomyelinsphingosine

Substanzen

SphingolipidsBlood Glucose

Autor:innen und Institutionen

  • Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Nawajes Mandal, Samuel Dagogo-Jack

Förderung

  • NIDDK NIH HHS
  • National Institutes of Diabetes Digestive and Kidney Diseases

Zitieren

APA

Asuzu, P., Aliye, N., Stentz, F., Wan, J., Mandal, N., & Dagogo-Jack, S. (2026). Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf378

Vancouver

Asuzu P, Aliye N, Stentz F, Wan J, Mandal N, Dagogo-Jack S. Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf378

BibTeX
@article{Asuzu2026,
  author = {Asuzu, Peace and Aliye, Naser and Stentz, Frankie and Wan, Jim and Mandal, Nawajes and Dagogo-Jack, Samuel},
  title = {Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf378}
}
Kostenlos starten →